PDCD1 and intrahepatic cholangiocarcinoma: Median stromal and intratumoral CD8 + PD-1+ TILs in ICC accounted for 1.1% (IQR 0.4–3.3%) and 2.0% (IQR 0.3–3.6%) of CD8+ TILs, respectively.